-
PDF
- Split View
-
Views
-
Cite
Cite
Emma K Sheriff, Fernanda Salvato, Shelby E Andersen, Anushila Chatterjee, Manuel Kleiner, Breck A Duerkop, Enterococcal quorum-controlled protease alters phage infection, FEMS Microbes, Volume 5, 2024, xtae022, https://doi.org/10.1093/femsmc/xtae022
- Share Icon Share
Abstract
Increased prevalence of multidrug-resistant bacterial infections has sparked interest in alternative antimicrobials, including bacteriophages (phages). Limited understanding of the phage infection process hampers our ability to utilize phages to their full therapeutic potential. To understand phage infection dynamics, we performed proteomics on Enterococcus faecalis infected with the phage VPE25. We discovered that numerous uncharacterized phage proteins are produced during phage infection of E. faecalis. Additionally, we identified hundreds of changes in bacterial protein abundances during infection. One such protein, enterococcal gelatinase (GelE), an fsr quorum-sensing-regulated protease involved in biofilm formation and virulence, was reduced during VPE25 infection. Plaque assays showed that mutation of either the quorum-sensing regulator fsrA or gelE resulted in plaques with a “halo” morphology and significantly larger diameters, suggesting decreased protection from phage infection. GelE-associated protection during phage infection is dependent on the putative murein hydrolase regulator LrgA and antiholin-like protein LrgB, whose expression have been shown to be regulated by GelE. Our work may be leveraged in the development of phage therapies that can modulate the production of GelE thereby altering biofilm formation and decreasing E. faecalis virulence.
Introduction
Enterococcus faecalis is a Gram-positive bacterium and a member of the gut microbiota of diverse animals, including humans (Sghir et al. 2000, Eckburg et al. 2005, Hayashi et al. 2005). Following prolonged antibiotic therapy, E. faecalis can outgrow other members of the microbiota and disseminate to the bloodstream, leading to life threatening diseases such as sepsis and endocarditis (Agudelo Higuita and Huycke 2014, Holland et al. 2016, Vogkou et al. 2016, Østergaard et al. 2022). Additionally, E. faecalis is a common cause of healthcare-associated infections (Huycke et al. 1998, Giacometti et al. 2000, Lake et al. 2018). Treatment of enterococcal infections is complicated by the increasing prevalence of multidrug-resistant (MDR) strains, including those resistant to “last-resort” antibiotics (Van Tyne and Gilmore 2014, Rice et al. 2018, Tyson et al. 2018, García-Solache and Rice 2019). With the ongoing antibiotic discovery gap and rising incidence of MDR infections, it is estimated that over 10 million individuals may die of antibiotic resistant infections per year by 2050, nearly 10 times the current yearly mortality (O’Neill 2016, Murray et al. 2022). Therefore, the development of innovative antimicrobial therapies is crucial to combating antibiotic resistant bacteria.
Bacteriophages (phages) are viruses that infect and kill bacteria. They have reemerged as potential therapeutics due to their diversity and abundance in nature, making them readily available for medical applications (Wigington et al. 2016, Williamson et al. 2017). Despite the discovery of phages over 100 years ago, we know little about the function of most phage-encoded genes (Twort 1915, D’Herelle 1917). Additionally, we have only a rudimentary understanding of how phages interact with their target bacteria, particularly in nonmodel hosts (Hatfull and Hendrix 2011). Understanding these fundamental aspects of phage biology is an important milestone toward the development of phages as antimicrobials.
During infection, phages co-opt host cellular processes to support their genome replication and translation of proteins responsible for virion assembly (Sergueev et al. 2002, Datta et al. 2005). One way that phages influence the bacterial response to infection is by modulating the cell density-dependent transcriptional program known as quorum sensing (QS) (Rossmann et al. 2015, Ali et al. 2017, Schroven et al. 2023, Schwartzkopf et al. 2024). Phage-mediated changes in QS gene regulation within a bacterial population can create an environment that is more permissible for infection (Schroven et al. 2023, Schwartzkopf et al. 2024). For example, changes in QS can result in the modification of wall teichoic acids, a major phage receptor, which contributes to phage infectivity (De Smet et al. 2016, Yang et al. 2023). In E. faecalis, high levels of the QS peptide AI-2 are associated with release of prophages, possibly resulting in the transfer of virulence genes (Rossmann et al. 2015). Additionally, E. faecalis QS itself is interrupted during phage infection, with decreased transcription of QS-induced genes and increased transcription of QS-repressed genes (Chatterjee et al. 2020).
QS in E. faecalis is controlled by the Fsr system (Qin et al. 2001, Ali et al. 2017). This system positively and negatively regulates the expression of hundreds of genes in response to bacterial density, as sensed by the extracellular abundance of the gelatinase biosynthesis-activating pheromone (GBAP) (Bourgogne et al. 2006, Del Papa and Perego 2011). There are three well-studied operons that demonstrate the highest fold-change in gene expression upon initial activation by the QS regulator FsrA (Bourgogne et al. 2006, Del Papa and Perego 2011, Teixeira et al. 2013). The first of these is the fsrBDC QS locus, which encodes the machinery for the QS system. This includes FsrC, the transmembrane sensor-transmitter; FsrD, a precursor of GBAP; and FsrB, which processes the FsrD propeptide into GBAP (Nakayama et al. 2001, 2006, Del Papa and Perego 2011). The second operon controlled by FsrA encodes the enterocin EntV, which has activity against Gram-positive bacteria, fungi, and Drosophila (Teixeira et al. 2013, Dundar et al. 2015, Graham et al. 2017). The final operon regulated by the Fsr QS system contains the genes gelE and sprE (Qin et al. 2001, Teixeira et al. 2013). Enterococcal gelatinase (GelE), or gelatinase, is a secreted metalloprotease frequently associated with virulence in enterococci and is vital for initiation of biofilm formation (Garsin et al. 2001, Engelbert et al. 2004, Mohamed et al. 2004, Gaspar et al. 2009, Thomas et al. 2009). SprE is a serine protease also associated with virulence (Garsin et al. 2001, Engelbert et al. 2004, Jha et al. 2005). In addition to its roles in virulence, GelE plays a role in the postprocessing of SprE and EntV (Kawalec et al. 2005, Brown et al. 2019). Additionally, GelE and SprE have both been shown to be involved in the postprocessing of the autolysin AtlA, although the role of SprE in this context has been contested (Thomas et al. 2009, Stinemetz et al. 2017).
In this paper, we used a proteomic approach to explore the interaction between the enterococcal phage VPE25 and its E. faecalis host. We found time-dependent trends in phage protein production and identified correlations between gene expression and protein abundance levels during infection. Investigation of the changes in bacterial protein abundance during phage predation revealed large-scale trends in the abundance of a wide variety of proteins. We show that decreased levels of the QS-regulated protein GelE, and subsequent downstream changes in the production of the murein hydrolase modulator LrgA and antiholin-like protein LrgB, influence the outcome of phage infection.
Materials and methods
Bacterial strains, bacteriophages, and plasmids
All bacterial strains used in this study have been previously published and are detailed in Table S1 (Qin 2000, Paulsen et al. 2003, Bourgogne et al. 2008, Thomas et al. 2008, Guiton et al. 2009, Dale et al. 2015, 2018, Graham et al. 2017). Transposon mutants selected from an arrayed library were confirmed using PCR (Dale et al. 2018). Phages, plasmids, and primers used in this study are also detailed in Table S1 (Trotter and Dunny 1990, Perez-Casal et al. 1991, Duerkop et al. 2016, Chatterjee et al. 2019, Sheriff et al. 2024). Enterococcus faecalis strains were grown in Todd–Hewitt broth (THB) with aeration or on THB agar plates at 37°C. Complementation and empty vectors were selected in E. faecalis strains using 15 μg/ml chloramphenicol or 10 µg/ml tetracycline as appropriate.
RNA-seq analysis
A previously published RNA-seq dataset, generated in a parallel experiment, was reanalyzed for phage transcript abundances (EMBL-EBI ArrayExpress database, accession number E-MTAB-8546) (Parkinson et al. 2007, Chatterjee et al. 2020). RNA sequencing reads were analyzed for quality using FastQC v0.12.0 (Andrews 2010). Reads were mapped to the VPE25 open reading frames (ORFs) using Salmon v1.10.2 (Patro et al. 2017). The output read quantities, as reported in the nascent quant.sf file, were used to create relative abundance calculations by dividing the transcripts per million (TPM) for a given ORF by the total number of TPMs for a sample. ORFs were ranked by their abundance for each timepoint, and this ranking was used to inform heatmap rings in Fig. 1(A), generated using the R package Circlize (Gu et al. 2014).

Phage infection of E. faecalis leads to diverse changes in protein expression. (A) Combined transcriptomic and proteomic data for phage VPE25. Each column represents one phage gene, with available gene annotations listed alongside corresponding columns. The outer three rings represent average TPM colored by rank at 10, 20, and 40 min postinfection. The innermost ring represents the % normalized spectral abundance factors (%NSAF) of each corresponding protein at 40 min postinfection. %NSAF abundance bars are color coded by the timepoint at which they are first identified as significantly differentially abundant (DA). (B) %NSAF values of the five most abundant phage proteins at 40 min postinfection are charted over the course of infection. Points represent an average of at least three biological replicates. Error bars represent standard deviation. (C) Volcano plot of bacterial proteins DA at 40 min postinfection between the infected and uninfected samples. Log2-transformed fold-change between the two samples is shown on the x-axis. Negative log10-transformed q-values are shown on the y-axis with a line at a significance cut-off of q < 0.05. Proteins with a q-value of zero were excluded. (D) %NSAF of GelE over time in both the infected and uninfected samples. Points represent an average of four biological replicates. Significance was determined using student’s t-tests corrected for multiple hypothesis testing using a permutation-based false discovery rate of 5%. Error bars represent standard deviation. * FDR ≤ 5%.
Preparation of samples for proteomics
Enterococcus faecalis cultures were infected with VPE25 as described previously (Chatterjee et al. 2020). Four replicate samples of 4 ml each were taken at 0, 10, 20, and 40 min after VPE25 treatment and pelleted. Pelleted samples were resuspended in 300 µl of SDT-lysis buffer (4% (w/v) SDS, 100 mM Tris-HCl, 0.1 M DTT). Cells were lysed by bead-beating using a Bead Ruptor Elite (OMNI) with Matrix Z beads (MP Biomedicals) for two cycles of 45 s at 6 m/s. Samples were incubated at 95°C for 10 min. Tryptic digests of protein extracts were prepared following the filter-aided sample preparation (FASP) protocol described previously, with minor modifications as described in Kleiner et al. (2017) and Wiśniewski et al. (2009). Lysate was not cleared by centrifugation after boiling the sample in lysis buffer. The whole lysate was loaded onto the filter units used for the FASP procedure. Centrifugation times were reduced to 20 min as compared to Kleiner et al. (2017). Peptide concentrations were determined with the Pierce Micro BCA assay (Thermo Scientific) using an Epoch2 microplate reader (Biotek) following the manufacturer’s instructions.
LC-MS/MS
All samples were analyzed by 1D-LC-MS/MS as described previously, with the modification that a 75-cm analytical column and a 140-min long gradient were used (Hinzke et al. 2019). For each sample run, 400 ng peptide were loaded with an UltiMateTM 3000 RSLCnano Liquid Chromatograph (Thermo Fisher Scientific) in loading solvent A (2% acetonitrile, 0.05% trifluoroacetic acid) onto a 5-mm, 300 µm ID C18 Acclaim® PepMap100 precolumn (Thermo Fisher Scientific). Separation of peptides on the analytical column (75 cm × 75 µm analytical EASY-Spray column packed with PepMap RSLC C18, 2 µm material, Thermo Fisher Scientific) was achieved at a flow rate of 300 nl/min using a 140-min gradient going from 95% buffer A (0.1% formic acid) to 31% buffer B (0.1% formic acid, 80% acetonitrile) in 102 min, then to 50% B in 18 min, to 99% B in 1 min, and ending with 99% B. The analytical column was heated to 60°C and was connected to a Q Exactive HF hybrid quadrupole-Orbitrap mass spectrometer (Thermo Fisher Scientific) via an Easy-Spray source. Eluting peptides were ionized via electrospray ionization. Carryover was reduced by one wash run (injection of 20 µl acetonitrile, 99% eluent B) between samples. Full scans were acquired in the Orbitrap at 60 000 resolution. The 15 most abundant precursor ions were selected for fragmentation and MS/MS scans were acquired at 15 000 resolution. The mass (m/z) 445.12003 was used as lock mass. Ions with charge state +1 were excluded from MS/MS analysis. Dynamic exclusion was set to 18 s. Roughly, 120 000 MS/MS spectra were acquired per sample.
Protein identification
A database containing protein sequences from E. faecalis OG1RF (NC_017316.1) and phage VPE25 (LT615366.1), both downloaded from NCBI, were used (Clark et al. 2016, O’Leary et al. 2016). Sequences of common laboratory contaminants were included by appending the cRAP protein sequence database (http://www.thegpm.org/crap/). The final database contained 2893 protein sequences. Searches of the MS/MS spectra against this database were performed with the Sequest HT node in Proteome Discoverer version 2.2.0.388 (Thermo Fisher Scientific) as previously described (Petersen et al. 2016). Only proteins identified with medium or high confidence were retained resulting in an overall false discovery rate of <5%.
Protein quantification and statistical analyses
For quantification of bacterial proteins, normalized spectral abundance factors (NSAFs) were calculated and multiplied by 100% to obtain relative protein abundance (Zybailov et al. 2006). The NSAF values were loaded into Perseus version 1.6.2.3 and log2 transformed (Tyanova et al. 2016). Only proteins with valid values in four replicates of at least one treatment were considered for further analysis. Missing values were replaced by a constant number that was lower than any value across the experiment. Differentially abundant (DA) proteins between conditions were calculated using student’s t-tests corrected for multiple hypothesis testing using a permutation-based false discovery rate of 5%. As the number of phage proteins is small and their relative abundances are heavily influenced by the overall abundance of the bacterial proteins in the cultures, we used a centered-log ratio (CLR) transformation for more robust analysis of compositional data (Fernandes et al. 2014). The CLR was calculated for all proteins, both phage and bacterial. CLR values for phage proteins were loaded into Perseus 1.6.2.3 where t-tests were performed as described above (Tyanova et al. 2016). Since the spectral counts at t0 (0 min postinfection) were much lower than the other time points, only proteins with 70% of total values across conditions with more than 20 peptide spectral matches (PSMs) were considered for comparisons with t0. For comparisons between the 10, 20, and 40 min postinfection time points, no PSM cut-off was employed. Replacement of missing values and t-tests were performed as described above.
Plaque assays
A volume of 1 ml of overnight bacterial culture was pelleted at 21 000 × g for 1 min and resuspended in 2 ml SM-plus phage buffer [100 mM NaCl, 50 mM Tris-HCl, 8 mM MgSO4, and 5 mM CaCl2 (pH 7.4)] (Duerkop et al. 2016). Approximately, 15 plaque-forming units (PFU) of phage were added to 120 μl of resuspended bacterial culture and incubated statically at room temperature for 5 min. Following incubation, 5 ml of molten THB top agar (0.35% agar, unless otherwise noted) supplemented with 10 mM MgSO4 was added to the suspension and poured over a 1.5% THB agar plate supplemented with 10 mM MgSO4. For supplementation of plates with spent media, overnight cultures of E. faecalis were subcultured to a starting OD600 of 0.025 and grown for 6 h to achieve maximum gelatinase activity. Spent media was pelleted at 4600 × g for 3 min, and supernatant was filtered through a 0.45-µm filter. Molten THB top agar (0.7% agar) was mixed 1:1 with filtered supernatant for a final concentration of 0.35% agar. Spent media top agar was supplemented with 10 mM MgSO4, and plaque assays were performed as described above. Plates were incubated upright at 37°C for 24 h unless otherwise noted. Photos of plates were taken on an iPhone 12, and plaque diameters were measured using ImageJ v1.53t (Schneider et al. 2012). A ruler was included in each image to determine scale.
Results
Assessment of VPE25 transcript and protein abundances during E. faecalis infection
To understand global protein regulation and abundances during phage infection of E. faecalis, we infected E. faecalis OG1RF with the siphophage VPE25 (Duerkop et al. 2016). Mid-log cultures of E. faecalis were infected with VPE25 at a multiplicity of infection of 10. Samples were taken at 0, 10, 20, and 40 min postinfection and subjected to LC-MS/MS-based proteomics analyses. We compared the phage-encoded protein abundances to a previously generated RNA-Seq dataset of VPE25 infected E. faecalis OG1RF, where the experimental parameters were identical (Chatterjee et al. 2020). From the RNAseq, we identified 131 phage transcripts throughout infection (Table S2). Proteomic analysis identified 93 of those transcripts as proteins (Table S3).
Figure 1(A) shows the VPE25 transcript and protein abundances throughout infection. Few proteins were detected at the initiation of infection, and it is likely that those detected were either present in the virion or rapidly expressed following DNA entry. Many replication proteins, such as DNA polymerase and DNA helicases, were significantly DA after only 10 min postinfection (Table S3). By 20 min postinfection, we saw increases in abundance of additional replication machinery, such as DNA gyrase subunits A and B. Virion components, primarily proteins involved in assembly of the tail, were also DA at this time, as was the phage lysin. Final virion components, including the portal protein and the head maturation protease, were DA by 40 min postinfection. Notably, the most abundant phage protein at each timepoint was the major capsid protein, whose relative abundance continued to increase throughout the course of infection (Fig. 1B, Table S3). The major capsid transcript levels reached the top ten most abundant phage transcripts at the 10-min timepoint and remained among the most abundant transcripts throughout infection (Table S2).
A high number of detected phage transcripts and proteins were annotated as genes of unknown function. Of the 133 putative genes in the VPE25 genome, more than 60% are hypothetical. Many of these uncharacterized proteins were expressed at a level equal to or above proteins with characterized functions. For example, SCO93409.1 is an uncharacterized phage protein whose abundance at 40 min was third only to the major capsid and major tail proteins (Fig. 1B). In silico analysis of these hypothetical proteins failed to provide insight on their potential function, with more than half having no conserved domains identified via InterProScan (Jones et al. 2014). Together these data show that the majority of VPE25 proteins are expressed during infection, many of which are proteins of unknown function.
Enterococcus faecalis responds to VPE25 infection by altering its gene expression and protein abundances
Our understanding of bacterial gene expression levels in response to phage infection and how this corresponds to protein abundances is limited. While transcript data is often used as a stand-in for shifts in proteomic abundances, comparative analyses show that these are often not fully concordant (Weintraub et al. 2019, Wolfram-Schauerte et al. 2022). In fact, many of the most DA bacterial proteins in our analysis are relatively unchanged at the transcript level when compared to our previously published RNA-Seq dataset (Table 1, Table S4) (Chatterjee et al. 2020).
Proteins with the 20 highest and lowest differential abundance ratio (DAR) values at 40 min postinfection.
Gene name . | Description . | DAR40 . | Recovered from transposon library? . |
---|---|---|---|
High DAR40 genes | |||
secY (OG1RF_10171) | Preprotein translocase subunit SecY | 86.97 | No, not present |
OG1RF_11743 | TetR/AcrR family transcriptional regulator | 52.26 | Yes |
OG1RF_11417 | Pyridoxal phosphate-dependent aminotransferase | 47.66 | Yes |
OG1RF_10804 | ATP-binding protein | 45.55 | Yes |
OG1RF_12485 | Alkaline phosphatase family protein | 40.55 | Yes |
phoU (OG1RF_11465) | Phosphate signaling complex protein | 40.16 | Yes |
OG1RF_10823 | AAA family ATPase | 34.49 | Yes |
OG1RF_11853 | Homoserine dehydrogenase | 33.26 | Yes |
yidC (OG1RF_11837) | Membrane protein insertase | 29.87 | Yes |
bgsB (OG1RF_12192) | Glycosyltransferase family 4 protein | 27.65 | Yes |
rsmG (OG1RF_12545) | 16S rRNA (guanine(527)-N(7))-methyltransferase | 27.43 | Yes |
OG1RF_11964 | Mur ligase family protein | 27.43 | No, not present |
citD (OG1RF_12566) | Citrate lyase acyl carrier protein | 24.39 | No, not present |
OG1RF_11639 | DUF3013 family protein | 23.06 | Yes |
dltA (OG1RF_12112) | d-alanine—poly(phosphoribitol) ligase subunit | 22.09 | Yes |
OG1RF_11645 | Class I SAM-dependent methyltransferase | 21.34 | No, not present |
OG1RF_10575 | Alanine ligase | 21.07 | No, not present |
OG1RF_12200 | NAD(P)/FAD-dependent oxidoreductase | 21.05 | No, not present |
OG1RF_12473 | tRNA-dihydrouridine synthase | 20.22 | Yes |
OG1RF_10734 | RNA-binding protein | 20.03 | Yes |
Low DAR40 genes | |||
gelE (OG1RF_11526) | M4 family metallopeptidase coccolysin | 0.00 | Yes |
OG1RF_10381 | Lipoate—protein ligase | 0.00 | Yes |
OG1RF_10282 | S-methyltransferase | 0.00 | Yes |
msrA (OG1RF_11394) | Peptide-methionine (S)-S-oxide reductase | 0.00 | No, not present |
OG1RF_11885 | DUF2129 domain-containing protein | 0.00 | Yes |
OG1RF_10952 | CsbD family protein | 0.08 | No, not present |
OG1RF_11211 | V-type ATPase subunit | 0.08 | Yes |
OG1RF_10532 | DUF1700 domain-containing protein | 0.09 | Yes |
OG1RF_11274 | Nucleotide pyrophosphohydrolase | 0.09 | No, not present |
OG1RF_10750 | PTS sugar transporter subunit IIB | 0.11 | No, not present |
opp2D (OG1RF_12370) | ABC transporter ATP-binding protein | 0.12 | Yes |
OG1RF_10751 | PTS lactose/cellobiose transporter subunit IIA | 0.13 | No, not present |
OG1RF_11463 | PspC domain-containing protein | 0.16 | No, not present |
OG1RF_10660 | AAA family ATPase | 0.16 | Yes |
OG1RF_11909 | Hypothetical protein | 0.17 | Yes |
OG1RF_12106 | MBL fold metallo-hydrolase | 0.17 | Yes |
atpF (OG1RF_11990) | F0F1 ATP synthase subunit B | 0.17 | No, not present |
OG1RF_11402 | LapA family protein | 0.17 | No, not present |
OG1RF_11033 | LTA synthase family protein | 0.17 | No, not present |
OG1RF_10795 | Hypothetical protein | 0.19 | Yes |
Gene name . | Description . | DAR40 . | Recovered from transposon library? . |
---|---|---|---|
High DAR40 genes | |||
secY (OG1RF_10171) | Preprotein translocase subunit SecY | 86.97 | No, not present |
OG1RF_11743 | TetR/AcrR family transcriptional regulator | 52.26 | Yes |
OG1RF_11417 | Pyridoxal phosphate-dependent aminotransferase | 47.66 | Yes |
OG1RF_10804 | ATP-binding protein | 45.55 | Yes |
OG1RF_12485 | Alkaline phosphatase family protein | 40.55 | Yes |
phoU (OG1RF_11465) | Phosphate signaling complex protein | 40.16 | Yes |
OG1RF_10823 | AAA family ATPase | 34.49 | Yes |
OG1RF_11853 | Homoserine dehydrogenase | 33.26 | Yes |
yidC (OG1RF_11837) | Membrane protein insertase | 29.87 | Yes |
bgsB (OG1RF_12192) | Glycosyltransferase family 4 protein | 27.65 | Yes |
rsmG (OG1RF_12545) | 16S rRNA (guanine(527)-N(7))-methyltransferase | 27.43 | Yes |
OG1RF_11964 | Mur ligase family protein | 27.43 | No, not present |
citD (OG1RF_12566) | Citrate lyase acyl carrier protein | 24.39 | No, not present |
OG1RF_11639 | DUF3013 family protein | 23.06 | Yes |
dltA (OG1RF_12112) | d-alanine—poly(phosphoribitol) ligase subunit | 22.09 | Yes |
OG1RF_11645 | Class I SAM-dependent methyltransferase | 21.34 | No, not present |
OG1RF_10575 | Alanine ligase | 21.07 | No, not present |
OG1RF_12200 | NAD(P)/FAD-dependent oxidoreductase | 21.05 | No, not present |
OG1RF_12473 | tRNA-dihydrouridine synthase | 20.22 | Yes |
OG1RF_10734 | RNA-binding protein | 20.03 | Yes |
Low DAR40 genes | |||
gelE (OG1RF_11526) | M4 family metallopeptidase coccolysin | 0.00 | Yes |
OG1RF_10381 | Lipoate—protein ligase | 0.00 | Yes |
OG1RF_10282 | S-methyltransferase | 0.00 | Yes |
msrA (OG1RF_11394) | Peptide-methionine (S)-S-oxide reductase | 0.00 | No, not present |
OG1RF_11885 | DUF2129 domain-containing protein | 0.00 | Yes |
OG1RF_10952 | CsbD family protein | 0.08 | No, not present |
OG1RF_11211 | V-type ATPase subunit | 0.08 | Yes |
OG1RF_10532 | DUF1700 domain-containing protein | 0.09 | Yes |
OG1RF_11274 | Nucleotide pyrophosphohydrolase | 0.09 | No, not present |
OG1RF_10750 | PTS sugar transporter subunit IIB | 0.11 | No, not present |
opp2D (OG1RF_12370) | ABC transporter ATP-binding protein | 0.12 | Yes |
OG1RF_10751 | PTS lactose/cellobiose transporter subunit IIA | 0.13 | No, not present |
OG1RF_11463 | PspC domain-containing protein | 0.16 | No, not present |
OG1RF_10660 | AAA family ATPase | 0.16 | Yes |
OG1RF_11909 | Hypothetical protein | 0.17 | Yes |
OG1RF_12106 | MBL fold metallo-hydrolase | 0.17 | Yes |
atpF (OG1RF_11990) | F0F1 ATP synthase subunit B | 0.17 | No, not present |
OG1RF_11402 | LapA family protein | 0.17 | No, not present |
OG1RF_11033 | LTA synthase family protein | 0.17 | No, not present |
OG1RF_10795 | Hypothetical protein | 0.19 | Yes |
Proteins with the 20 highest and lowest differential abundance ratio (DAR) values at 40 min postinfection.
Gene name . | Description . | DAR40 . | Recovered from transposon library? . |
---|---|---|---|
High DAR40 genes | |||
secY (OG1RF_10171) | Preprotein translocase subunit SecY | 86.97 | No, not present |
OG1RF_11743 | TetR/AcrR family transcriptional regulator | 52.26 | Yes |
OG1RF_11417 | Pyridoxal phosphate-dependent aminotransferase | 47.66 | Yes |
OG1RF_10804 | ATP-binding protein | 45.55 | Yes |
OG1RF_12485 | Alkaline phosphatase family protein | 40.55 | Yes |
phoU (OG1RF_11465) | Phosphate signaling complex protein | 40.16 | Yes |
OG1RF_10823 | AAA family ATPase | 34.49 | Yes |
OG1RF_11853 | Homoserine dehydrogenase | 33.26 | Yes |
yidC (OG1RF_11837) | Membrane protein insertase | 29.87 | Yes |
bgsB (OG1RF_12192) | Glycosyltransferase family 4 protein | 27.65 | Yes |
rsmG (OG1RF_12545) | 16S rRNA (guanine(527)-N(7))-methyltransferase | 27.43 | Yes |
OG1RF_11964 | Mur ligase family protein | 27.43 | No, not present |
citD (OG1RF_12566) | Citrate lyase acyl carrier protein | 24.39 | No, not present |
OG1RF_11639 | DUF3013 family protein | 23.06 | Yes |
dltA (OG1RF_12112) | d-alanine—poly(phosphoribitol) ligase subunit | 22.09 | Yes |
OG1RF_11645 | Class I SAM-dependent methyltransferase | 21.34 | No, not present |
OG1RF_10575 | Alanine ligase | 21.07 | No, not present |
OG1RF_12200 | NAD(P)/FAD-dependent oxidoreductase | 21.05 | No, not present |
OG1RF_12473 | tRNA-dihydrouridine synthase | 20.22 | Yes |
OG1RF_10734 | RNA-binding protein | 20.03 | Yes |
Low DAR40 genes | |||
gelE (OG1RF_11526) | M4 family metallopeptidase coccolysin | 0.00 | Yes |
OG1RF_10381 | Lipoate—protein ligase | 0.00 | Yes |
OG1RF_10282 | S-methyltransferase | 0.00 | Yes |
msrA (OG1RF_11394) | Peptide-methionine (S)-S-oxide reductase | 0.00 | No, not present |
OG1RF_11885 | DUF2129 domain-containing protein | 0.00 | Yes |
OG1RF_10952 | CsbD family protein | 0.08 | No, not present |
OG1RF_11211 | V-type ATPase subunit | 0.08 | Yes |
OG1RF_10532 | DUF1700 domain-containing protein | 0.09 | Yes |
OG1RF_11274 | Nucleotide pyrophosphohydrolase | 0.09 | No, not present |
OG1RF_10750 | PTS sugar transporter subunit IIB | 0.11 | No, not present |
opp2D (OG1RF_12370) | ABC transporter ATP-binding protein | 0.12 | Yes |
OG1RF_10751 | PTS lactose/cellobiose transporter subunit IIA | 0.13 | No, not present |
OG1RF_11463 | PspC domain-containing protein | 0.16 | No, not present |
OG1RF_10660 | AAA family ATPase | 0.16 | Yes |
OG1RF_11909 | Hypothetical protein | 0.17 | Yes |
OG1RF_12106 | MBL fold metallo-hydrolase | 0.17 | Yes |
atpF (OG1RF_11990) | F0F1 ATP synthase subunit B | 0.17 | No, not present |
OG1RF_11402 | LapA family protein | 0.17 | No, not present |
OG1RF_11033 | LTA synthase family protein | 0.17 | No, not present |
OG1RF_10795 | Hypothetical protein | 0.19 | Yes |
Gene name . | Description . | DAR40 . | Recovered from transposon library? . |
---|---|---|---|
High DAR40 genes | |||
secY (OG1RF_10171) | Preprotein translocase subunit SecY | 86.97 | No, not present |
OG1RF_11743 | TetR/AcrR family transcriptional regulator | 52.26 | Yes |
OG1RF_11417 | Pyridoxal phosphate-dependent aminotransferase | 47.66 | Yes |
OG1RF_10804 | ATP-binding protein | 45.55 | Yes |
OG1RF_12485 | Alkaline phosphatase family protein | 40.55 | Yes |
phoU (OG1RF_11465) | Phosphate signaling complex protein | 40.16 | Yes |
OG1RF_10823 | AAA family ATPase | 34.49 | Yes |
OG1RF_11853 | Homoserine dehydrogenase | 33.26 | Yes |
yidC (OG1RF_11837) | Membrane protein insertase | 29.87 | Yes |
bgsB (OG1RF_12192) | Glycosyltransferase family 4 protein | 27.65 | Yes |
rsmG (OG1RF_12545) | 16S rRNA (guanine(527)-N(7))-methyltransferase | 27.43 | Yes |
OG1RF_11964 | Mur ligase family protein | 27.43 | No, not present |
citD (OG1RF_12566) | Citrate lyase acyl carrier protein | 24.39 | No, not present |
OG1RF_11639 | DUF3013 family protein | 23.06 | Yes |
dltA (OG1RF_12112) | d-alanine—poly(phosphoribitol) ligase subunit | 22.09 | Yes |
OG1RF_11645 | Class I SAM-dependent methyltransferase | 21.34 | No, not present |
OG1RF_10575 | Alanine ligase | 21.07 | No, not present |
OG1RF_12200 | NAD(P)/FAD-dependent oxidoreductase | 21.05 | No, not present |
OG1RF_12473 | tRNA-dihydrouridine synthase | 20.22 | Yes |
OG1RF_10734 | RNA-binding protein | 20.03 | Yes |
Low DAR40 genes | |||
gelE (OG1RF_11526) | M4 family metallopeptidase coccolysin | 0.00 | Yes |
OG1RF_10381 | Lipoate—protein ligase | 0.00 | Yes |
OG1RF_10282 | S-methyltransferase | 0.00 | Yes |
msrA (OG1RF_11394) | Peptide-methionine (S)-S-oxide reductase | 0.00 | No, not present |
OG1RF_11885 | DUF2129 domain-containing protein | 0.00 | Yes |
OG1RF_10952 | CsbD family protein | 0.08 | No, not present |
OG1RF_11211 | V-type ATPase subunit | 0.08 | Yes |
OG1RF_10532 | DUF1700 domain-containing protein | 0.09 | Yes |
OG1RF_11274 | Nucleotide pyrophosphohydrolase | 0.09 | No, not present |
OG1RF_10750 | PTS sugar transporter subunit IIB | 0.11 | No, not present |
opp2D (OG1RF_12370) | ABC transporter ATP-binding protein | 0.12 | Yes |
OG1RF_10751 | PTS lactose/cellobiose transporter subunit IIA | 0.13 | No, not present |
OG1RF_11463 | PspC domain-containing protein | 0.16 | No, not present |
OG1RF_10660 | AAA family ATPase | 0.16 | Yes |
OG1RF_11909 | Hypothetical protein | 0.17 | Yes |
OG1RF_12106 | MBL fold metallo-hydrolase | 0.17 | Yes |
atpF (OG1RF_11990) | F0F1 ATP synthase subunit B | 0.17 | No, not present |
OG1RF_11402 | LapA family protein | 0.17 | No, not present |
OG1RF_11033 | LTA synthase family protein | 0.17 | No, not present |
OG1RF_10795 | Hypothetical protein | 0.19 | Yes |
Of the 2647 genes in the E. faecalis OG1RF genome, 2550 were detected as transcripts (Chatterjee et al. 2020). Of those transcripts, 1225 proteins were detected using proteomics. A total of 680 proteins were DA between infected and uninfected E. faecalis by 40 min (Fig. 1C, Table S4). There was no statistical difference in bacterial protein relative abundances at the 10-min timepoint, and at 20 min postinfection only six proteins were DA (Fig. S1A). The limited differences in protein abundances at the earlier timepoints reflect a lag time between the transcriptional response, which begins by the 10-min timepoint, and the time it takes to translate those transcripts into proteins (Chatterjee et al. 2020). All of the DA proteins at 20 min remained DA at the 40-min timepoint with the exception of OG1RF_12042, a CYTH domain-containing protein.
The differential abundance ratio (DAR) was calculated as the relative change in abundance of a protein between the infected and uninfected samples at each timepoint. The DAR at 40 min (DAR40) was used to identify potential key effectors of bacteria–phage interactions during infection (Table 1). Proteins with high DAR values, such as SecY, are at an increased level during phage infection, while proteins with low DAR values, like AtpF, are found in decreased abundance during phage infection. This up- and downregulation of protein abundances can be attributed to the bacterium responding to phage infection or when phage-encoded proteins hijack bacterial host processes leading to changes in protein abundances. To determine which, if any, of these proteins may be integral to phage virulence during infection, we used mutants from an arrayed E. faecalis OG1RF transposon library and screened them for changes in phage infectivity (Dale et al. 2018). Mutants selected represent available transposon insertions in genes whose proteins were most over- or under-represented at 40 min as indicated by DAR (Table 1). While no differences were seen in the number of viable PFU on each strain tested (Fig. S1B), a change in plaque morphology was noted on the gelE-Tn mutant, a protein whose expression is undetected at 40 min (Fig. 1D).
Enterococcus faecalis gelatinase alters phage infection
VPE25 forms clear plaques with a well-defined border ~1 mm in diameter on E. faecalis OG1RF. However, after 24 h of plaque formation on an in-frame gelE deletion strain (OG1RF∆gelE), VPE25 forms a central zone of clearing surrounded by a large turbid ring, which more than doubles the overall diameter (Fig. 2A). This phenotype suggests that when GelE is absent, bacterial cells are more susceptible to phage infection associated factors. This “halo” morphology is rescued through the addition of gelE on a constitutive expression vector (pLZ12A:: gelE) (Fig. 2B and C). The gelE gene encodes enterococcal gelatinase, a secreted protease that targets a variety of substrates and is regulated by the Fsr QS system (Mäkinen et al. 1989, Mäkinen and Mäkinen 1994, Qin et al. 2001, Waters et al. 2003, Kawalec et al. 2005, Park et al. 2007, 2008, Teixeira et al. 2013, Brown et al. 2019). GelE is one of five proteins, which were undetected in phage-infected samples by 40 min postinfection and thus has a DAR of 0, supporting our previous finding that the transcription of QS-regulated genes, including gelE, are significantly lower during phage infection (Table 1, Table S4) (Chatterjee et al. 2020). While the proteomics analyses were performed in infected liquid cultures, it appears that GelE is downregulated in plates as well, albeit at a slower rate. Specifically, as infection progresses in plates, plaques on OG1RF, which were previously nonhaloed begin to develop small haloes. Plaques on OG1RF and OG1RF∆gelE + pLZ12A:: gelE phenocopy each other at 24 h; however, the overexpression of gelE prevents the development of these small halos and significantly limits the overall plaque diameter at the 48-h timepoint (Fig. 2C and D).

Phage VPE25 plaque morphology is altered in the absence of gelE. (A) VPE25 plaques on an E. faecalis OG1RF top agar overlay are small with distinct edges, while plaques on an OG1RF∆gelE overlay are larger and have a halo phenotype. (B) Complementation of OG1RF∆gelE with gelE on a plasmid (OG1RF∆gelE:: gelE). (A and B) Clear edges of the central lytic zones of plaques are denoted with a black arrow. Where present, halo edges are denoted with a red arrow. (C) Average plaque diameters are significantly larger in OG1RF∆gelE and OG1RF∆gelE:: EV than in OG1RF or OG1RF∆gelE:: gelE. Data represents average plaque diameter at 24 h from three biological replicates. (D) Plaque diameter is significantly smaller over time on the OG1RF∆gelE:: gelE complement strain. Data represents average plaque diameter at 48 h from four biological replicates. (E) VPE25 plaques on OG1RF∆fsrA are significantly larger than on OG1RF. Data represents average plaque diameter at 24 h from eight biological replicates. (F) Average plaque diameters are significantly larger than wild type in overlays of E. faecalis sprE-Tn when compared to OG1RF. Data represents average plaque diameter at 24 h from five biological replicates. (G) Plaque diameter on OG1RF∆gelE varies with concentration of agar in top agar overlay. Data represents average plaque diameter at 24 h from four biological replicates. Significance was determined using two-way ANOVA with multiple comparisons. (H) Addition of spent media from OG1RF cultures added to top agar overlays partially abrogates the halo morphology in OG1RF∆gelE. Diameter of VPE25 plaques in an OG1RF∆gelE overlay is significantly smaller when OG1RF spent media is added compared to plaque diameter upon the addition of OG1RF∆gelE spent media. Data represents average plaque diameter at 72 h from four biological replicates. (C, F, and H) Significance determined using one-way ANOVA with multiple comparisons. (D and E) Significance determined using unpaired t-test. (C, D, E, F, G, and H) Error bars represent standard deviation. **** P ≤ .0001, *** .0001 < P ≤ .001, ** .001 < P ≤ .01, * .01 < P ≤ .05, ns = not significant.
To further investigate this phenotype, we assessed phage plaque morphology on E. faecalis OG1RF∆fsrA, a strain lacking the QS master regulator fsrA. Again, plaques showed a halo morphology, and plaque diameter was significantly larger than wild type (Fig. 2E). GelE cleaves the target proteins EntV and SprE, which are both under the control of FsrA, as well as AtlA, an autolysin that is involved in biofilm formation (Qin et al. 2001, Kawalec et al. 2005, Thomas et al. 2009, Dundar et al. 2015, Graham et al. 2017, Stinemetz et al. 2017, Brown et al. 2019). We tested deletion mutants of entV, sprE, and atlA for plaque morphology during VPE25 infection. Deletion of entV or atlA showed no change in plaque morphology or size, but a sprE transposon mutant strain formed haloed plaques similar to OG1RF∆gelE and OG1RF∆fsrA (Fig. 2F). GelE-dependent changes in the viability of extracellular virions and the ability of VPE25 phages to adsorb to E. faecalis cells were also tested; however, we observed no significant differences regardless of the presence or absence of GelE (Fig. S2B and C).
The top agar overlay plaque assay supports the diffusion of both phage and secreted factors, such as GelE, through the top agar. We varied the agar density to look for changes in plaque size to determine if this phenotype is associated with diffusion. Plaque assays were performed using either double (0.7% agar) or half (0.175% agar) the normal concentration of soft agar in the overlay, while all other parameters remained constant. As the agar concentration within the overlay increased, the size of VPE25 plaques and their halos on OG1RF∆gelE decreased (Fig. 2G). However, when wild type OG1RF is infected with VPE25, the average plaque diameter does not change regardless of the agar concentration, suggesting that GelE diffusion is indeed responsible for this phenotype.
Because GelE is secreted and diffusible within the agar, we hypothesized that the addition of spent media from wild type OG1RF cultures could limit the development of haloed plaques on OG1RF∆gelE. Spent media from cultures of OG1RF wild type or OG1RF∆gelE was supplemented into plaque assays for both OG1RF and OG1RF∆gelE. No significant changes in diameter were observed in plaques on OG1RF regardless of the spent media used. However, the addition of OG1RF wild type spent media significantly reduced the size of plaques on OG1RF∆gelE at the 72-h timepoint (Fig. 2H). This phenotype is only significant at this late timepoint as the initial small differences in plaque diameter become more apparent as plaques continue to grow over time.
Additional E. faecalis strains and phages show altered infectivity that is dependent on GelE
To determine if the haloed plaque morphology was unique to E. faecalis OG1RF and VPE25, we tested VPE25 plaque morphology on E. faecalis V583, a genetically distinct vancomycin-resistant isolate (Bourgogne et al. 2008). In a gelE mutant of V583 (V583∆gelE), VPE25 plaques develop a similar halo morphology, and the plaque diameter is significantly larger when compared to wild type cells (Fig. 3A). However, unlike OG1RF∆gelE, the halo morphology is not well-observed at 24 h and is only prominent in the V583 background after 48 h (Fig. S3A). The halos observed in V583∆gelE are also present in a double deletion of both gelE and sprE (V583∆gelE∆sprE), but not present in the sprE deletion alone (V583∆sprE) (Fig. 3A).

Distinct phages and E. faecalis strains are impacted by the presence of GelE. (A) Average plaque diameter on V583∆gelE and V583∆gelE∆sprE is significantly larger than wild type V583. Data represents average plaque diameter at 48 h from three biological replicates. Significance was determined using one-way ANOVA with multiple comparisons. (B) The plaque diameter of VPE25 and G01 plaques is significantly larger on an overlay of OG1RF∆gelE when compared to OG1RF. Data represents average plaque diameter at 48 h from five biological replicates. Significance determined using two-way ANOVA with multiple comparisons. (A and B) Error bars represent standard deviation. **** P ≤ .0001, *** .0001 < P ≤ .001, ns = not significant.
To determine if this halo plaque morphology was unique to the phage VPE25, we used a panel of genetically distinct phages and measured plaque diameters on OG1RF and OG1RF∆gelE. In addition to VPE25, the phage G01 produced a halo phenotype and significantly larger plaques after 48 h of infection (Fig. 3B). G01 is a 41-kb phage isolated from the Ganges River in India (Sheriff et al. 2024). While both VPE25 and G01 are siphophages with icosahedral heads and noncontractile tails, the two phages share greater than 30% nucleotide identity in only four genes as identified via clinker (Fig. S4A) (Gilchrist and Chooi 2021). Specifically, these homologous genes encode a lysin, glutaredoxin, a DUF1140 domain-containing protein, and a hypothetical protein. Interestingly, while the VPE25 and G01 lysins share 65% identity across 66% coverage, most of the homology is focused in the amidase domain (Fig. S4B) (Altschul et al. 1997). These data indicate that GelE-mediated plaque morphology is neither E. faecalis strain- or phage-dependent.
GelE regulation of the murein hydrolase regulator lrgA and antiholin-like protein lrgB provides protection from phage-mediated inhibition
Previous work in E. faecalis V583 demonstrated an upregulation of the lrgAB operon in the presence of gelE (Teixeira et al. 2013). While the function of the lrgAB locus is uncharacterized in E. faecalis, LrgA and LrgB are involved in repression of murein hydrolase activity and decreased autolysis in Staphylococcus aureus and their expression is dependent on the Agr QS system (Fujimoto et al. 2000, Groicher et al. 2000). We hypothesized that lrgA and/or lrgB play a role in limiting phage-mediated haloed plaque formation. The lrgAB locus is regulated by the LytSR two-component system, located directly upstream of its operon. LytSR is hypothesized to activate in the presence of extracellular GelE, after which it increases transcription of lrgAB (Teixeira et al. 2013). While the functions of lrgA and lrgB have not been studied extensively in enterococci, they have been shown to be upregulated during growth in blood (Vebø et al. 2009).
Considering the role of LrgA and LrgB in limiting murein hydrolase activity, we hypothesized that they may be involved in protection against phage-mediated extracellular lysis. VPE25 plaque diameters on lytS-Tn and lytR-Tn mutants were significantly larger than wild type (Fig. 4A). Next, the plaque assay was repeated with lrgA-Tn and lrgB-Tn mutants, showing that plaque diameters are significantly larger than wild type OG1RF (Fig. 4B). Complementation of these genes restores plaque diameters to that of wild type OG1RF (Fig. 4A and B). Together, our data suggest that the murein hydrolase regulator LrgA and the antiholin LrgB are ultimately responsible for the altered plaque morphology in the absence of GelE and support the notion that this activity is mediated first by GelE and then by the LytSR two-component system. The underabundance of proteins like GelE during phage infection may be due in part to phage-mediated changes in enterococcal QS to facilitate an environment more permissible to phage infection. This is further supported by the increased phage-dependent inhibition seen on plates in the absence of these genes.

Mutation of lrgA and lrgB genes results in altered plaque morphology. (A) Average plaque diameter on E. faecalis lytS-Tn and lytR-Tn mutants is significantly larger than on OG1RF or complemented strains. (B) Average plaque diameter on lrgA-Tn and lrgB-Tn mutants is significantly larger than on wild type or complemented strains. (A and B) Data represents average plaque diameter at 24 h from five biological replicates. Significance determined using one-way ANOVA with multiple comparisons. Error bars represent standard deviation. **** P ≤ .0001, *** .0001 < P ≤ .001, * .01 < P ≤ .05, ns = not significant.
Discussion
The continued rise in antibiotic resistant bacterial infections has led to renewed interest in alternative antimicrobials, including phages. However, gaps in our understanding of phage biology and infection dynamics limit the full potential of emerging phage therapeutics. In this study, we used proteomics to probe the complexities of phage infection and understand the interplay between phages and E. faecalis. The resulting dataset provided insights into the timing of phage protein expression during infection, as well as identifying altered abundances of hundreds of bacterial proteins during infection, primarily those involved in cell wall remodeling and bacterial metabolism. Additionally, this work revealed a role for the FsrA-regulated protease GelE, and to a lesser extent the protease SprE, in driving phenotypic changes in phage plaque morphology. This phenotypic change is due to ablated activity of the murein hydrolase regulator LrgA and the antiholin LrgB, which we hypothesize aid in protection from increased phage-mediated attack (Fig. 5). Future development of phages for clinical application may exploit this phenotype to allow for phage modulation of the virulence factor GelE to reduce E. faecalis virulence.

Enterococcal quorum-controlled proteases alter phage infection. Model figure summarizing the interactions between the Fsr QS system, GelE, SprE, LytS, LytR, LrgA, LrgB, and phage VPE25 during infection of E. faecalis.
GelE was investigated because it is significantly underabundant during phage infection (Fig. 1C and D, Table 1, Table S4). Because GelE is a secreted protein, our methodology may have limited its detection. However, the observation that GelE is significantly underabundant during phage infection is consistent with the repression of QS-regulated transcripts during phage infection of E. faecalis, including gelE and sprE (Chatterjee et al. 2020). Gelatinase has been previously characterized as a virulence factor and has a role in the formation of biofilms, which are well-penetrated by phages (Mohamed et al. 2004, Thomas et al. 2009, Khalifa et al. 2015, Melo et al. 2016, Morris et al. 2019). These data suggest that, in addition to aiding in the dispersal of biofilms, phages can limit biofilm initiation through repression of gelE. Further research may elucidate phage factors responsible for mediating the repression of enterococcal QS during infection. Inclusion of an identified gene or genes in a therapeutic phage may aid treatment by repressing the expression of Fsr-regulated virulence factors (Kawalec et al. 2005, Park et al. 2007, Del Papa and Perego 2011). GelE is secreted and thus cells, which do not produce GelE can take advantage of the gelatinase produced by neighboring bacteria as cheaters (Thomas et al. 2009, Teixeira et al. 2012). However, the supplementation of extracellular gelatinase is not sufficient to fully eliminate the halo plaque phenotype, suggesting partial abrogation of gelatinase activity may still be therapeutically beneficial (Fig. 2H).
While the absence of gelE is associated with the development of haloed plaques in both E. faecalis OG1RF and V583, deletion of sprE results in changes to plaque morphology only in OG1RF (Fig. 2C, F, and 3A). These strains share 98.82% and 99.30% amino acid identity across the full sequences of GelE and SprE, respectively (Altschul et al. 1997). With such high similarity and a well-characterized role for GelE in the postprocessing of SprE, it remains unclear why interruption of sprE does not result in haloed plaques in V583 (Kawalec et al. 2005). It is possible that SprE, in addition to GelE, is required for processing a downstream factor, which is processed by GelE alone in V583, or in conjunction with an alternative protease. Postprocessing by GelE is known to impact the localization of the autolysin AtlA on the cell surface (Stinemetz et al. 2017). Bacteria often acquire phage resistance through mutations that result in changes to the structure of cell wall-associated molecules (Duerkop et al. 2016, Chatterjee et al. 2019). While the haloed plaques reported here are not dependent on AtlA, characterization of additional changes to the cell surface in the absence of gelE, sprE, or both may provide insight into the mechanism of this phenotype (Fig. 2F).
Interruption of lrgA and lrgB, which are positively regulated in the presence of GelE, also resulted in the haloed plaque morphology (Fig. 4B) (Teixeira et al. 2013). It is it unlikely that LrgA and LrgB are directly involved in the adsorption or phage DNA entry process. VPE25 infection is a two-step process. First, VPE25 adsorbs to E. faecalis by interacting with the enterococcal polysaccharide antigen (EPA) (Chatterjee et al. 2019). Mutation of epa genes results in a significant adsorption deficiency and a lack of productive infection (Chatterjee et al. 2020). Following EPA engagement, VPE25 then requires interaction with the integral membrane protein PIPEF to facilitate DNA entry (Duerkop et al. 2016). In the absence of PIPEF, VPE25 virions can adsorb to the E. faecalis cell surface but fail to eject their genomes into the host cytoplasm. LrgA and LrgB are known to repress murein hydrolase activity and autolysis in S. aureus, suggesting a potential role for these proteins in limiting phage-mediated extracellular lysis (Groicher et al. 2000). Further elucidating the mechanism of LrgAB-conferred protection will inform our understanding of how these proteins function during phage infection of E. faecalis. The similarity between the amidase domains of the G01 and VPE25 lysins, as well as the role of LrgA and LrgB in the repression of murein hydrolase activity, suggests that LrgA and LrgB may provide protection against extracellular phage lysis or “lysis from without” (Fig. 4B, Fig. S4B) (Abedon 2011).
Similar haloed plaque morphologies have been associated with the presence of phage depolymerases (Wu et al. 2019, Vukotic et al. 2020). These phage-encoded proteins can degrade a variety of bacterial polysaccharides, including capsular, extracellular, and lipopolysaccharides (Leiman et al. 2007, Cornelissen et al. 2012, Olszak et al. 2017). Although phage depolymerases have been previously associated with similar plaque phenotypes, analysis using InterProScan did not reveal any Pfam matches for such depolymerases within the genomes of phages VPE25 or G01 (Jones et al. 2014). While the mechanism of GelE-conferred protection from phage-mediated inhibition is still unknown, phages which are able to modulate the production of virulence factors such as GelE should be considered for their potential role in future therapeutic applications. Taken together, our work here provides an understanding of phage infection at the protein level and demonstrates a protective role for GelE, LrgA, and LrgB during phage infection (Fig. 5).
Acknowledgments
All LC-MS/MS measurements were made in the Molecular Education, Technology, and Research Innovation Centre (METRIC) at NC State University. The authors would like to thank Dr Julia Willett, Dr Kimberly Kline, and Dr Danielle Garsin for providing bacterial strains used in this work.
Conflict of interest
None declared.
Funding
This work was supported by the National Institutes of Health grants R01AI141479 (B.A.D.) and R35GM138362 (M.K.).
Data Availability
The proteomic data (MS raw files and search results) and the protein sequence database have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD026873 (Vizcaíno et al. 2016).